The Simmons Hanly Conroy pharmaceutical lawyers are dedicated to providing you with the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls and warning label changes, medical studies and other pharmaceutical news taking place across the globe .
-
- Antidote for anticoagulant Pradaxa to be tested in Hamilton
Five Canadian hospitals are participating in a clinical trial that tests an antidote for Pradaxa, a blood-thinning medication that has been linked to serious bleeding. The drug’s manufacturer, Boehringer Igelheim, hopes the antidote will be able to reverse the serious effects of Pradaxa’s anticlotting abilities.
- Antidote for anticoagulant Pradaxa to be tested in Hamilton
-
- Takeda Ordered to Pay More Than $2 Million to Actos User
A jury recently ordered Takeda Pharmaceutical Co., the maker of Actos, to pay more than $2 million to a woman who claimed the use of the drug caused her to develop bladder cancer. The jury found that the company failed to warn about the link and the drug clearly caused the cancer. - FDA: little evidence to drop Chantix boxed warning
The FDA has decided against dropping the boxed warning on Chantix. In fact, some groups say the warning should be stronger.
- Takeda Ordered to Pay More Than $2 Million to Actos User
